Year Founded
1923
Ownership
Public
Employees
~2042
Therapeutic Areas
PulmonologyMen's HealthOtherRare DiseasesInfectious Diseases
Stage
Commercial
Modalities
Small moleculeLarge moleculeMedical devices

Kyorin Pharmaceutical General Information

Japanese pharmaceutical company with marketed products in respiratory, infectious diseases and allergy areas

Contact Information

Website
Primary Industry
[ "Biotech", "Pharma" ]
Corporate Office
Tokyo,
Japan

Drug Pipeline

pentoxifylline
Commercial
Indications: Lorem ipsum dolor sit
Modality: Lorem ipsum
Drug Asset 2
Phase X
Indications: Lorem ipsum dolor sit
Modality: Lorem ipsum
Drug Asset 3
Phase X
Indications: Lorem ipsum dolor sit
Modality: Lorem ipsum

For full access to Kyorin Pharmaceutical's pipeline data

Book a demo

Key Partnerships

Need more data on over 80,000 life science companies, including over 1200 biotechs?

Book a demo

Kyorin Pharmaceutical Funding

No funding data available

Early Stage VC (Series A)04-Jun-2020$38MCompletedPhase 1
Seed Round12-Feb-2019$8.5MCompletedStartup

Interested in comprehensive profile data?

We'll help you find what you need

Learn more
To view Kyorin Pharmaceutical's complete valuation and funding history, request access »

Kyorin Pharmaceutical Investors

Not publicly disclosed; publicly traded company.
Investor Type: Venture Capital
Holding: Minority